Literature DB >> 1713449

Production of MUC1 and MUC2 mucins by human tumor cell lines.

P L Devine1, G T Layton, B A Clark, G W Birrell, B G Ward, P X Xing, I F McKenzie.   

Abstract

A mucus secreting, clonal derivative (HT29-SB) of the human colonic adenocarcinoma cell line HT29, and the LS174T colon cancer cell line, secrete mucin into the culture medium as a viscoelastic gel. Mab BC2, which defines a peptide epitope present in the variable number of tandem repeats (VNTR) of the MUC1 core protein, reacted with this material after deglycosylation. Two high molecular weight bands were detected in TFMSA treated gel-formed mucin from HT29-SB and LS174T by western blotting (Mr 580 kDa and 420 kDa). A similar pattern of reactivity was seen with the culture supernatants from HT29-SB, the ovarian tumor cell line COLO-316, and the breast cancer cell line MCF-7. Mab CCP58 (anti-MUC2 VNTR) reacted with a 580 kDa band in gel-formed mucin produced by LS174T, but was not reactive with mucin produced by the other cell lines. The findings indicate that human colonic cell lines, in addition to breast and ovarian cell lines, may both express and secrete the MUC1 protein core, and that the LS174T cell line expresses and secretes both the MUC1 and MUC2 core proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713449     DOI: 10.1016/0006-291x(91)90149-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Biosynthesis of the MUC2 mucin: evidence for a slow assembly of fully glycosylated units.

Authors:  J K Sheehan; D J Thornton; M Howard; I Carlstedt; A P Corfield; C Paraskeva
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

3.  Biosynthesis and secretion of mucin-related products in Hs746T gastric cancer cells.

Authors:  S Sano; K Okazaki; Y Yamamoto
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

5.  The human intestinal cell lines Caco-2 and LS174T as models to study cell-type specific mucin expression.

Authors:  B J van Klinken; E Oussoren; J J Weenink; G J Strous; H A Büller; J Dekker; A W Einerhand
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

6.  Expression of MUC2 epithelial mucin in breast carcinoma.

Authors:  M D Walsh; M A McGuckin; P L Devine; B G Hohn; R G Wright
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

7.  Biliopancreatic fistula caused by an intraductal papillary-mucinous tumor of the pancreas confirmed by biochemical analysis of mucin.

Authors:  Shuichi Sano; Isao Nishimori; Nobuto Okamoto; Takuhiro Kohsaki; Saburo Onishi; Masanori Morita; Keijiro Araki
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  Biosynthesis of mucin derived from a 60-kDa precursor protein in the human stomach.

Authors:  S Sano; K Okazaki; Y Yamamoto; A Slomiany; B L Slomiany
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

9.  Synthesis and secretion of mucin by the human colonic tumour cell line LS180.

Authors:  D J McCool; J F Forstner; G G Forstner
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

Review 10.  Immunotherapy for colorectal cancer.

Authors:  K A Foon
Journal:  Curr Oncol Rep       Date:  2001-03       Impact factor: 5.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.